Literature DB >> 10831087

Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation.

J P Rerolle1, K Akposso, N Lerolle, B Mougenot, T Ponnelle, E Rondeau, J D Sraer.   

Abstract

BACKGROUND: Hemolytic uremic syndrome (HUS) is a rare complication in solid organ transplantation. It can be associated with severe hypertension. Several risk factors have been identified including immunosuppressive drugs such as cyclosporin A and, more recently, tacrolimus.
METHODS: Here we report a case of tacrolimus-induced HUS in a 61-yr-old woman after liver transplantation. Hypertension, microangiopathic anemia and end-stage renal failure occurred 2 yr after liver transplantation.
RESULTS: At admission, she had malignant hypertension with a severe hypertensive retinopathy, renal failure (creatininemia: 800 micromol/L) and microangiopathic anemia (Hb: 7.3 g/dL, a low platelet count and elevated lactate dehydrogenase). At renal biopsy, histologic findings were ischemic and sclerotic glomeruli with hyaline thrombi, severe mesangiolysis and interstitial fibrosis.
CONCLUSION: Despite steroid treatment, antihypertensive agents and fresh frozen plasma therapy, end-stage renal failure was observed and chronic hemodialysis treatment was required.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10831087     DOI: 10.1034/j.1399-0012.2000.140314.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  2 in total

1.  Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan.

Authors:  Tomohide Hori; Toshimi Kaido; Fumitaka Oike; Yasuhiro Ogura; Kohei Ogawa; Yukihide Yonekawa; Koichiro Hata; Yoshiya Kawaguchi; Mikiko Ueda; Akira Mori; Hajime Segawa; Kimiko Yurugi; Yasutsugu Takada; Hiroto Egawa; Atsushi Yoshizawa; Takuma Kato; Kanako Saito; Linan Wang; Mie Torii; Feng Chen; Ann-Marie T Baine; Lindsay B Gardner; Shinji Uemoto
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

Review 2.  Thrombocytopenia after liver transplantation: Should we care?

Authors:  Kazuhiro Takahashi; Shunji Nagai; Mohamed Safwan; Chen Liang; Nobuhiro Ohkohchi
Journal:  World J Gastroenterol       Date:  2018-04-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.